Ignite Creation Date:
2025-12-24 @ 7:32 PM
Ignite Modification Date:
2026-02-22 @ 5:09 PM
Study NCT ID:
NCT00798603
Status:
COMPLETED
Last Update Posted:
2017-01-25
First Post:
2008-11-25
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Pemetrexed, Carboplatin, and Bevacizumab as First-Line Therapy in Treating Older Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Sponsor:
Alliance for Clinical Trials in Oncology
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Lung Cancer | View |